Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 337

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Open access
Amraei, Razie, Yin, Wenqing, Napoleon, Marc A., Suder, Ellen L., Berrigan, Jacob, Zhao, Qing, Olejnik, Judith, Chandler, Kevin Brown, Xia, Chaoshuang, Feldman, Jared, Hauser, Blake M., Caradonna, Timothy M., Schmidt, Aaron G., Gummuluru, Suryaram, Mühlberger, Elke, Chitalia, Vipul, Costello, Catherine E., Rahimi, Nader·2021·ACS Central Science

Abstract

Abstract As the COVID-19 pandemic continues to spread, investigating the processes underlying the interactions between SARS-CoV-2 and its hosts is of high importance. Here, we report the identification of CD209L/L-SIGN and the related protein CD209/DC-SIGN as receptors capable of mediating SARS-CoV-2 entry into human cells. Immunofluorescence staining of human tissues revealed prominent expression of CD209L in the lung and kidney epithelium and endothelium. Multiple biochemical assays using a purified recombinant SARS-CoV-2 spike receptor binding domain (S-RBD) or S1 encompassing both NTB and RBD and ectopically expressed CD209L and CD209 revealed that CD209L and CD209 interact with S-RBD. CD209L contains two N- glycosylation sequons, at sites N92 and N361, but we determined that only site N92 is occupied. Removal of the N -glycosylation at this site enhances the binding of S-RBD with CD209L. CD209L also interacts with ACE2, suggesting a role for heterodimerization of CD209L and ACE2 in SARS-CoV-2 entry and infection in cell types where both are present. Furthermore, we demonstrate that human endothelial cells are permissive to SARS-CoV-2 infection and interference with CD209L activity by knockdown strategy or with soluble CD209L inhibits virus entry. Our observations demonstrate that CD209L and CD209 serve as alternative receptors for SARS-CoV-2 in disease-relevant cell types, including the vascular system. This property is particularly important in tissues where ACE2 has low expression or is absent, and may have implications for antiviral drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acscentsci.0c01537

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 337

Metadata

Authors
Amraei, R., Yin, W., Napoleon, M. A., Suder, E. L., Berrigan, J., Zhao, Q., Olejnik, J., Chandler, K. B., Xia, C., Feldman, J., Hauser, B. M., Caradonna, T. M., Schmidt, A. G., Gummuluru, S., Mühlberger, E., Chitalia, V., Costello, C. E., & Rahimi, N.
Venue
ACS Central Science
Published
2021-06-30
Volume
7
Issue
7
Pages
1156-1165
ISSN
  • 2374-7943 (ISSN-L)
  • 2374-7951
OpenAlex
W3174184935
Cited by
337
References
52
FWCI
20.88
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. https://app.cochat.ai/papers/10.1021/acscentsci.0c01537
The paper
Amraei, R., Yin, W., Napoleon, M. A., Suder, E. L., Berrigan, J., Zhao, Q., Olejnik, J., Chandler, K. B., Xia, C., Feldman, J., Hauser, B. M., Caradonna, T. M., Schmidt, A. G., Gummuluru, S., Mühlberger, E., Chitalia, V., Costello, C. E., & Rahimi, N. (2021). CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Central Science. https://doi.org/10.1021/acscentsci.0c01537

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.